Hemolytic phenotype analysis of Staphylococcus aureus clinical isolates

Acta Universitatis Medicinalis Anhui     font:big middle small

Found programs: National Natural Science Foundation of China (No . 82102460)

Authors:Gao Ju , Weng Shengnan , Leng Guiyun , Li Xin , Yao Jie , Zhou Qiang, Tang Wei

Keywords:Staphylococcus aureus;clinical isolate;hemolytic phenotype;hemolysin; antibiotic resistance;virulence

DOI:10.19405/j.cnki.issn1000-1492.2025.07.021

〔Abstract〕 To investigate the hemolytic phenotypes of Staphylococcus aureus clinical isolates . Methods The hemolytic phenotypes of 105 Staphylococcus aureus isolates were analyzed and summarized using the three-point inoculation method . Real-time fluorescence quantitative PCR was used to measure the mRNA expression levels of four hemolysin genes (hla , hlb , hlc , and hld) ; The VITEK 2 GP639 antimicrobial susceptibility card was used to detect resistance to commonly used antibiotics; DNA gel electrophoresis was performed to determine the prevalence of the mecA , sea , tst , and pvl genes; The microtiter plate crystal violet staining method was used to assess biofilm formation ability; The CCK-8 assay was used to evaluate cytotoxicity against macrophages . Results Seven hemo- lytic phenotypes were identified among the Staphylococcus aureus clinical isolates . Differences were found among Staphylococcus aureus clinical isolates with different hemolytic phenotypes in terms of mRNA expression levels of he- molysin genes , antibiotic resistance , virulence gene prevalence , biofilm formation ability , and cytotoxicity to mouse macrophages ( P < 0. 05 ) . Conclusion Staphylococcus aureus clinical isolates exhibit diverse hemolytic pheno- types , which should be a focus across multiple dimensions , including microbiological testing , clinical treatment , and nosocomial infection prevention and control .